Difference between revisions of "Part:BBa K209023"
(→2018 Peking Team improvement) |
MichaelYang (Talk | contribs) |
||
Line 21: | Line 21: | ||
Team Peking 2018 improved this part. | Team Peking 2018 improved this part. | ||
− | + | Firstly, we fused this this part with yEGFP, which made it visible in the yeast under fluorescent microscope. | |
https://parts.igem.org/Part:BBa_K2601008 | https://parts.igem.org/Part:BBa_K2601008 | ||
− | Then | + | Then we characterized the expression of FKBP-yEGFP with 3 promoters pTet07, pTEF1 and PDH3. The expression of these promoters was measured through flow cytometry. |
https://parts.igem.org/Part:BBa_K2601025 | https://parts.igem.org/Part:BBa_K2601025 | ||
Line 31: | Line 31: | ||
https://parts.igem.org/Part:BBa_K2601027 | https://parts.igem.org/Part:BBa_K2601027 | ||
− | + | Moreover, we fused FKBP-yEGFP with HOtag3. This part can form phase separation with Frb-yEGFP-HOTag6 in the presence of rapamycin. | |
https://parts.igem.org/Part:BBa_K2601011 | https://parts.igem.org/Part:BBa_K2601011 | ||
− | + | Finally, we characterized the expression of FKBP-yEGFP-HOTag3 with 2 promoters pTEF1 and PDH3. The expression of these promoters was measured by flow cytometry. | |
https://parts.igem.org/Part:BBa_K2601037 | https://parts.igem.org/Part:BBa_K2601037 | ||
https://parts.igem.org/Part:BBa_K2601038 | https://parts.igem.org/Part:BBa_K2601038 |
Revision as of 21:15, 16 October 2018
Aar1 C-D part, FKBP
dimerizes with FRB when rapamycin is present
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
2018 Peking Team improvement
Team Peking 2018 improved this part.
Firstly, we fused this this part with yEGFP, which made it visible in the yeast under fluorescent microscope.
https://parts.igem.org/Part:BBa_K2601008
Then we characterized the expression of FKBP-yEGFP with 3 promoters pTet07, pTEF1 and PDH3. The expression of these promoters was measured through flow cytometry.
https://parts.igem.org/Part:BBa_K2601025 https://parts.igem.org/Part:BBa_K2601026 https://parts.igem.org/Part:BBa_K2601027
Moreover, we fused FKBP-yEGFP with HOtag3. This part can form phase separation with Frb-yEGFP-HOTag6 in the presence of rapamycin.
https://parts.igem.org/Part:BBa_K2601011
Finally, we characterized the expression of FKBP-yEGFP-HOTag3 with 2 promoters pTEF1 and PDH3. The expression of these promoters was measured by flow cytometry.
https://parts.igem.org/Part:BBa_K2601037 https://parts.igem.org/Part:BBa_K2601038